{"id":74310,"date":"2026-09-10T14:09:56","date_gmt":"2026-09-10T12:09:56","guid":{"rendered":"https:\/\/dasgoetheanum.com\/?p=74310"},"modified":"2026-09-10T14:33:08","modified_gmt":"2026-09-10T12:33:08","slug":"dynamic-development","status":"publish","type":"post","link":"https:\/\/dasgoetheanum.com\/en\/dynamic-development\/","title":{"rendered":"Dynamic Development"},"content":{"rendered":"\n<p>Weleda\u2019s shareholders\u2019 meeting and the interview<span id='easy-footnote-1-74310' class='easy-footnote-margin-adjust'><\/span><span class='easy-footnote'><a href='https:\/\/dasgoetheanum.com\/en\/dynamic-development\/#easy-footnote-bottom-1-74310' title='Read the full interview here: &lt;a href=&quot;https:\/\/dasgoetheanum.com\/en\/the-new-weleda\/&quot; target=&quot;_blank&quot; rel=&quot;noreferrer noopener&quot;&gt;\u201cThe New Weleda,\u201d&lt;\/a&gt; &lt;em&gt;Das Goetheanum English Issue 2026\/36&lt;\/em&gt;.'><sup>1<\/sup><\/a><\/span> took place over three months ago at the end of May 2026. Time marches on. Within the anthroposophic medicine (AM) movement, among the major shareholders, and at Weleda, the focus has shifted to new issues. The rejuvenation of the brand and the accelerated growth of the cosmetics division were successful, but that came at a price. Now there are other issues that require attention and resources. This has been recognized and the issues are being worked on.<\/p>\n\n\n\n<p>Further steps are needed to maintain a healthy equity ratio (and, by extension, the company\u2019s independence) as well as to restore the ability to pay dividends; the board of directors and management are currently working on these steps. Shareholders and participants are anticipating these dividends. As cultural institutions for higher learning, research, and training, the Goetheanum and the Arlesheim Clinic need these funds\u2014the fruits of which will undoubtedly strengthen Weleda in the long term.<\/p>\n\n\n\n<p>The anthroposophic medical movement now finds itself in opposition to official policy in Germany. This summer health insurance companies stopped covering the cost of anthroposophic remedies. The reason given: their effectiveness has not been scientifically proven. This assessment did not come about overnight, but it is now a fact. The entire AM movement is in a challenging situation. And this applies, in a new way, to Weleda and all other manufacturers of anthroposophic medicines. How can this crisis (and Weleda\u2019s pharmaceutical division has been in crisis for quite some time) be used to generate new momentum for an anthroposophic medicine that is firmly rooted in society?<\/p>\n\n\n\n<p>Despite a strong first half-year in sales in the cosmetics sector, Weleda faces intense challenges as fall begins.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<p><strong>Translation<\/strong> Laura Liska<br><strong>Image <\/strong>Tina M\u00fcller (CEO of Weleda), Thomas Jorberg, and Ueli Hurter (members of the Weleda Board of Directors) in conversation with Wolfgang Held; photo: Eliza Rozeboom<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Weleda\u2019s shareholders\u2019 meeting and the interview took place over three months ago at the end of May 2026. Time marches on. Within the anthroposophic medicine (AM) movement, among the major shareholders, and at Weleda, the focus has shifted to new issues. The rejuvenation of the brand and the accelerated growth of the cosmetics division were successful, but that came at a price. Now there are other issues that require attention and resources. This has been recognized and the issues are [&hellip;]<\/p>\n","protected":false},"author":9317,"featured_media":74048,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[8796],"tags":[11831,11835,8819],"class_list":["post-74310","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-column","tag-ausgabe-35-2026-en","tag-english-issue-37-2026","tag-seeds"],"acf":[],"_links":{"self":[{"href":"https:\/\/dasgoetheanum.com\/en\/wp-json\/wp\/v2\/posts\/74310","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dasgoetheanum.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dasgoetheanum.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dasgoetheanum.com\/en\/wp-json\/wp\/v2\/users\/9317"}],"replies":[{"embeddable":true,"href":"https:\/\/dasgoetheanum.com\/en\/wp-json\/wp\/v2\/comments?post=74310"}],"version-history":[{"count":3,"href":"https:\/\/dasgoetheanum.com\/en\/wp-json\/wp\/v2\/posts\/74310\/revisions"}],"predecessor-version":[{"id":74329,"href":"https:\/\/dasgoetheanum.com\/en\/wp-json\/wp\/v2\/posts\/74310\/revisions\/74329"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dasgoetheanum.com\/en\/wp-json\/wp\/v2\/media\/74048"}],"wp:attachment":[{"href":"https:\/\/dasgoetheanum.com\/en\/wp-json\/wp\/v2\/media?parent=74310"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dasgoetheanum.com\/en\/wp-json\/wp\/v2\/categories?post=74310"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dasgoetheanum.com\/en\/wp-json\/wp\/v2\/tags?post=74310"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}